tert-Butyl 4-oxo-1,4'-bipiperidine-1'-carboxylate

Catalog No. :
ACEUJA608
CAS No. :
1185732-60-8
Molecular Formula :
C15H26N2O3
Molecular Weight :
282.38

IUPAC Name:tert-butyl 4-oxo-[1,4'-bipiperidine]-1'-carboxylate

tert-Butyl 4-oxo-1,4'-bipiperidine-1'-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$204.00Login to see priceIn stockIn stock
250mg95%$336.00Login to see priceIn stockIn stock
1g95%$595.00Login to see priceIn stockInquiry
5g95%$2524.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-oxo-1,4'-bipiperidine-1'-carboxylate
IUPAC Nametert-butyl 4-oxo-[1,4'-bipiperidine]-1'-carboxylate
MDL No.MFCD09953098
Molecular FormulaC15H26N2O3
Molecular Weight282.38
SMILESO=C(N1CCC(N2CCC(CC2)=O)CC1)OC(C)(C)C
InChI KeyFXZGHIFLLWIBQD-UHFFFAOYSA-N
SynonymTERT-BUTYL 4-OXO-1,4;tert-butyl 4-(4-oxopiperidin-1-yl)piperidine-1-carboxylate;[1,4'-Bipiperidine]-1'-carboxylic acid, 4-oxo-, 1,1-dimethylethyl ester;tert-Butyl 4-oxo-1,4'-bipiperidine-1'-carboxylate
CAS No.1185732-60-8
PubChem CID53419028

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACEUJA608 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGQBV941 route compound structure diagram
    ACGQBV941367500-88-7 In Stock
  2. Then
  3. ACEUJA608 route product structure diagram
    ACEUJA6081185732-60-8 In Stock
Inquiry

2. ACEUJA608 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEUJA608 route product structure diagram
    ACEUJA6081185732-60-8 In Stock
Inquiry

Comments (0)